Experienced in Chondrosarcoma

Gilles Dolivet

Nancy, FR 
Experienced in Chondrosarcoma
Nancy, FR 
OverviewLocationsClinical Research

Overview

Gilles Dolivet practices in Nancy, France. Mr. Dolivet is rated as an Experienced expert by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Chondrosarcoma, Laryngectomy, and Endoscopy.

His clinical research consists of co-authoring 64 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Chondrosarcoma.

Gender
Male

Locations

Nancy, 54000, France
Other Locations
Vandoeuvre-les-nancy, 54519, France
54519, France
Toulouse, 31059, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase III Study of LI [Multikine®] Plus SOC (Surgery + Radiotherapy or Surgery + Concurrent Radiochemotherapy) in Subjects With Advanced Primary Squamous Cell Carcinoma of the Oral Cavity/Soft Palate vs. SOC Only
Phase III Study of LI [Multikine®] Plus SOC (Surgery + Radiotherapy or Surgery + Concurrent Radiochemotherapy) in Subjects With Advanced Primary Squamous Cell Carcinoma of the Oral Cavity/Soft Palate vs. SOC Only
Enrollment Status: Completed
Publish Date: August 19, 2022
Intervention Type: Dietary supplement, Drug, Procedure, Biological, Radiation
Study Drugs: Multikine, Cyclophosphamide, Indomethacin, Cisplatin
Study Phase: Phase 3
A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With Oral Potentially Malignant Lesions (OPML) or Head and Neck Squamous Cell Carcinoma (HNSCC) (IHNPACT UMBRELLA)
A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With Oral Potentially Malignant Lesions (OPML) or Head and Neck Squamous Cell Carcinoma (HNSCC) (IHNPACT UMBRELLA)
Enrollment Status: Terminated
Publish Date: October 08, 2020
Intervention Type: Behavioral, Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

64 Total Publications

Fluorescence Imaging-Assessed Surgical Margin Detection in Head and Neck Oncology by Passive and Active Targeting.
Fluorescence Imaging-Assessed Surgical Margin Detection in Head and Neck Oncology by Passive and Active Targeting.
Journal: Molecular diagnosis & therapy
Published: April 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dolivet's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile